Jiksak Bioengineering Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Jiksak Bioengineering General Information

Description

Developer of neuron-targeted drug delivery technologies designed for neurodegenerative disease treatment. The company's platform delivers therapeutic candidates directly into neurons through natural biological pathways and supports nerve repair and neurological research, enabling biotechnology and pharmaceutical markets to develop treatments for ALS and other neurological disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Cybernics Medical Innovation Base-A Room 322
  • 3-25-16 Tonomachi, Kawasaki-ku
  • Kawasaki, Kanagawa 210-0821
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Cybernics Medical Innovation Base-A Room 322
  • 3-25-16 Tonomachi, Kawasaki-ku
  • Kawasaki, Kanagawa 210-0821
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Jiksak Bioengineering Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 18-Mar-2026 Completed Generating Revenue
7. Later Stage VC (Series B) 29-Aug-2022 Completed Generating Revenue
6. Accelerator/Incubator 01-Oct-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Feb-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 22-Feb-2018 Completed Startup
3. Accelerator/Incubator 01-Feb-2018 Completed Startup
2. Angel (individual) 21-Apr-2017 $136K $136K Completed Startup
1. Accelerator/Incubator 01-Feb-2017 Completed Startup
To view Jiksak Bioengineering’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Jiksak Bioengineering Patents

Jiksak Bioengineering Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026086103-A In vitro pain model and method for measuring pain using same Pending 14-Nov-2024
WO-2026079407-A1 Targeting agent Pending 08-Oct-2024
WO-2025089341-A1 Anti-synaptic vesicle glycoprotein 2c antibody Inactive 25-Oct-2023
WO-2025089342-A1 Anti-synaptic vesicle glycoprotein 2c antibody Inactive 25-Oct-2023
WO-2025089343-A1 Anti-synaptic vesicle glycoprotein 2c antibody Inactive 25-Oct-2023
To view Jiksak Bioengineering’s complete patent history, request access »

Jiksak Bioengineering Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jiksak Bioengineering Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
CEJ Capital Corporate Venture Capital Minority
Cyberdyne Corporation Minority
SBI Investment Venture Capital Minority
Zeon (Tokyo) Corporation Minority
JAPAN CONVENTION SERVICES Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Jiksak Bioengineering FAQs

  • When was Jiksak Bioengineering founded?

    Jiksak Bioengineering was founded in 2017.

  • Where is Jiksak Bioengineering headquartered?

    Jiksak Bioengineering is headquartered in Kawasaki, Japan.

  • What is the size of Jiksak Bioengineering?

    Jiksak Bioengineering has 10 total employees.

  • What industry is Jiksak Bioengineering in?

    Jiksak Bioengineering’s primary industry is Drug Discovery.

  • Is Jiksak Bioengineering a private or public company?

    Jiksak Bioengineering is a Private company.

  • What is Jiksak Bioengineering’s current revenue?

    The current revenue for Jiksak Bioengineering is .

  • How much funding has Jiksak Bioengineering raised over time?

    Jiksak Bioengineering has raised $7.63M.

  • Who are Jiksak Bioengineering’s investors?

    CEJ Capital, Cyberdyne, SBI Investment, Zeon (Tokyo), and JAPAN CONVENTION SERVICES are 5 of 8 investors who have invested in Jiksak Bioengineering.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process